Related Experiment Video
Updated: Dec 13, 2025

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality
Published on: April 7, 2023
Determining the Impact of Roller Compaction Processing Conditions on Granule and API Properties
James Clarke1, John F Gamble2, John W Jones3
1School of Chemical Engineering, University of Birmingham, Birmingham, B15 2TT, UK.
Drug particle attrition during dry granulation impacts dosage form performance. This study found comminuted drug particles can remain free in roller compaction blends, aiding process optimization.
Area of Science:
- Pharmaceutical Technology
- Materials Science
- Chemical Engineering
Background:
- Drug particle attrition during dry granulation affects final dosage form performance.
- The fate of comminuted particles within granules is not fully understood.
- Understanding attrition and incorporation is key to optimizing granulation processes.
Purpose of the Study:
- To investigate drug particle attrition during dry granulation.
- To determine the incorporation of comminuted particles into granules using a Gerteis equipment train.
- To enhance the understanding of granulation performance and process modeling.
Main Methods:
- Examined attrition of Active Pharmaceutical Ingredient (API) particles.
- Utilized a Gerteis roller compaction equipment train for dry granulation.
- Analyzed post-milling blends to identify comminuted drug particles.
Main Results:
- Confirmed that comminuted drug particles can exist freely in post-milling blends.
- Demonstrated the presence of attrited API particles within the granulation mixture.
- Provided insights into particle behavior during roller compaction.
Conclusions:
- Comminuted drug particles are present in roller compaction blends.
- This finding aids in understanding granulation performance.
- Enables improved mechanistic models for process optimization.
Related Concept Videos
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
Shape and Texture of Coarse Aggregate
Compacting Factor test
The procedure begins by placing concrete into the upper hopper without any compaction. Once filled, the bottom door of this hopper is opened,...
Factors Affecting Workability

